Fourth generation cephalosporins in the antimicrobial chemotherapy of surgical infections

Journal of Chemotherapy

Volumn 11, Issue 6, 1999, Pages 486-493

  Giamarellou, H ^a  

^a SISMANOGLIO HOSPITAL   (Greece)

Author keywords

Cefepime; Cefpirome; Cephalosporins; Surgical infections

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAMASE; CEFEPIME; CEFOTAXIME; CEFPIROME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; METRONIDAZOLE; NITROIMIDAZOLE DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTEROIDES FRAGILIS; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE SEVERITY; DRUG INDICATION; ENTEROBACTER; HOSPITAL INFECTION; HUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; SURGICAL INFECTION;

EID: 0033395445     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1999.11.6.486     Document Type: Conference Paper

References (26)

1. 1 Montravers P, Gauzit R, Muller C, Marmuse JP, Fichelle A, Desmonts JM. Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy. Clin Infect Dis 1996; 23: 486-494.
2. 2 Finegold SM, Wexler HM. Present status of therapy for anaerobic infections. Clin Infect Dis 1996; 23 (S1): 9-14.
3. 3 Mosdell DM, Morris DM, Volturo A, et al. Antibiotic treatment for surgical peritonitis. Ann Surg 1991; 214: 543-549.
4. 4 Goldstein EJ. Possible role for the new fluoroquinolones in the treatment of anaerobic infections: review of current information on efficacy and safety. Clin Infect Dis 1996; 23 (S1): 25-30.
5. 5 Phillips I, King A, Nord CE, Hoffstedt B. Antibiotic sensitivity of the Bacteroides fragilis group in Europe, European Study Group. Eur J Clin Microbiol Infect Dis 1992, 11: 292-304.
6. 6 Brook J, Gillmore JD. Increased resistance of encapsulated Bacteroides fragilis to clindamycin. Chemotherapy 1994; 40: 16-20.
7. 7 Hedberg M, Nord CE. Beta-lactam resistance in anaerobic bacteria: a review. J Chemother 1996; 8: 3-16.
8. 8 Bourgault AM, Lamothe F. Update on pan-American activities in the field of anaerobes: Canada. Clin Infect Dis 1997; 25 (S2): 237-240.
9. 9 Sanders CC, Sanders WE. Beta-lactam resistance in Gram-negative bacteria: global trends and clinical impact. Clin Infect Dis 1992; 15: 824-839.
10. 10 Laroche M, Harding G. Primary and secondary peritonitis: An update. Eur J Clin Microbiol Infect Dis 1998; 17: 542-550.
11. 11 Solomkin JS, Meakins JL, Allo MD, et al. Antibiotic trials in intra-abdominal infections. A critical evaluation of study design and outcome reporting. Ann Surg 1984; 200: 29-39.
12. 12 Stone HH, Bourneuf AA, Stinson LD. Reliability of criteria for predicting persistent or recurrent sepsis. Arch Surg 1985; 120: 17-20.
13. 13 Giamarellou H. Clinical experience with the fourth generation cephalosporins. J Chemother 1996; 8 (S2): 91-104.
14. 14 Giamarellou H. Low-dosage cefepime treatment for serious bacterial infections. J Antimicrob Chemother 1993; 32 (SB): 175-186.
15. 15 Barradell LB, Bryson HM. Cefepime: a review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 1994; 47: 471-505.
16. 16 Giamarellou H, Sahin A, Chryssouli Z. Comparative in vitro evaluation of BMY-28142, a new broad-spectrum cephlosporin, versus other beta-lactams against multiresistant Gram-negative isolates. Drugs Exp Clin Res 1987; 13: 149-153.
17. 17 Nathens AB, Rotstein OD, Marshall JC. Tertiary peritonitis: Clinical features of a complex nosocomial infection. W J Surg 1998; 22: 158-163.
18. 18 Ehrhardt AF, Sanders CC. Beta-lactam resistance amongst Enterobacter species. J Antimicrob Chemother 1993; 32 (SB): 1-11.
19. 19 Burnett RJ, Hverstock DC, Dellinger PE, et al. Definition of the role of Enterococcus in intraabdominal infection: Analysis of a prospective randomized trial. Surgery 1995; 118: 716-723.
20. 20 Okamoto MP, Gill MA, Nakahiro RK, et al. Cefepime pharmacokinetics in patients with acute cholecystitis undergoing cholecystectomy. Clin Pharm 1993; 12: 134-137.
21. 21 Järvinen HJ, Hästbecke J. Early cholecystectomy for acute cholecystitis. Ann Surg 1980; 191: 501-505.
22. 22 Yellin AE, Berne TV, Applemman MD, et al. A randomized study of cefepime versus the combination of gentamicin and mezlocillin as an adjunct to surgical treatment in patients with acute cholecystitis. Surg Gynecol Obstet 1993; 177 (S): 23-29.
23. 23 Thompson JEJr, Bennion RS, Roettger R, Lally KP, Hopkins JA, Wilson SE. Cefepime for infections of the biliary tract. Surg Gynecol Obstet 1993; 177 (S): 30-34.
24. 24 Berne TV, Yellin AE, Appleman MD, Haseltine PNR, Gill MA. A clinical comparison of cefepime and metronidazole versus gentamicin and clindamycin in the antibiotic management of surgically treated advanced appendicitis. Surg Gynecol Obstet 1993; 177 (S): 18-22.
25. 25 Barie PS, Vogel SB, Dellinger EP, et al. A randomised, double-blind clinical trial comparing cefepime plus metronidazole with imipenem-cilastatin in the treatment of complicated intraabdominal infections. Cefepime Intraabdominal Infection Study Group. Arch Surg 1997; 132: 1294-1302.
26. 26 Cohen ML. Epidemiology of drug resistance: Implications for a post-antimicrobial era. Science 1992; 257: 1050-1055.